RedShift BioAnalytics
Signal active
Organization
Contact Information
Overview
RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind.
The company was founded in 2005 and is headquartered in Burlington, Massachusetts.
About
Industries
Enterprise Software, Biotechnology, Life Science, Electronics, Manufacturing, Product Design
Founded
2005
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
RedShift BioAnalytics headquartered in United States, North America, operates in the Enterprise Software, Biotechnology, Life Science, Electronics, Manufacturing, Product Design sector. The company focuses on Enterprise Software and has secured $11.0B in funding across 168 round(s). With a team of 1-10 employees, RedShift BioAnalytics is actively contributing to advancements in Enterprise Software. Their latest funding round, Series A - RedShift BioAnalytics, raised $12.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
6
Lead Investors
0
Total Funding Amount
$65.7M
Details
5
RedShift BioAnalytics has raised a total of $65.7M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Late Stage Venture | 20.0M | ||
| 2017 | Late Stage Venture | 11.0M | ||
| 2013 | Early Stage Venture | 3.0M | ||
| 2006 | Early Stage Venture | 12.0M |
Investors
RedShift BioAnalytics is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Waters Corporation | - | FUNDING ROUND - Waters Corporation | 11.0M |
| Bryson D. Hollimon | - | FUNDING ROUND - Bryson D. Hollimon | 11.0M |
| RedShift BioAnalytics | - | FUNDING ROUND - RedShift BioAnalytics | 11.0M |
| Technology Venture Partners | - | FUNDING ROUND - Technology Venture Partners | 11.0M |
Recent Activity
There is no recent news or activity for this profile.